SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-012020
Filing Date
2015-01-15
Accepted
2015-01-15 17:25:06
Documents
3
Period of Report
2015-01-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d852904d8k.htm 8-K 14473
2 EX-99.1 d852904dex991.htm EX-99.1 6260
3 GRAPHIC g852904img5.jpg GRAPHIC 8704
  Complete submission text file 0001193125-15-012020.txt   34191
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15530702
SIC: 2834 Pharmaceutical Preparations